SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001341004-23-000115 from 2U, Inc. (TWOUQ) (CIK 0001459417)

2U, Inc. (TWOUQ) (CIK 0001459417)
Date: April 21, 2023 · CIK: 0001459417 · Accession: 0001341004-23-000115

AI Filing Summary & Sentiment

File numbers found in text: 001-36376

Referenced dates: April 10, 2023

Date
April 21, 2023
Author
/s/Richard L. Oliver
Form
CORRESP
Company
2U, Inc. (TWOUQ) (CIK 0001459417)

Letter

VIA EDGAR Division of Corporation Finance Office of Technology Securities and Exchange Commission Re: 2U, Inc. Form 10-K for the Fiscal Year Ended December 31, 2022 Form 8-K filed February 2, 2023 File No. 001-36376

Dear Mr. Littlepage:

On behalf of our client, 2U, Inc. (the “Company”), we are submitting this letter in response to the comments from the staff (the “Staff”) of the Division of Corporation Finance of the Securities and Exchange Commission (the “Commission”) set forth in the letter dated April 10, 2023 (the “Comment Letter”) concerning the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “Form 10-K”) and the Current Report on Form 8-K filed February 2, 2023 (the “Form 8-K”). For convenience, the Staff’s comments are set forth below, followed by the Company’s responses.

Office of Technology

April 21, 2023

Page 2

Form 10-K for the Fiscal Year Ended December 31, 2022

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Liquidity and Capital Resources, page 54

Comment

1.

We note you discuss your ability to meet your working capital and capital expenditure requirements for the next 12 months. Please expand your disclosure to address your ability to generate and obtain adequate amounts of cash to meet your cash requirements in the long-term. We refer to guidance in Item 303 of Regulation S-K.

Response

In future filings, the Company will expand its disclosure within the Management’s Discussion & Analysis (“MD&A”) section to address its ability to generate and obtain adequate amounts of cash to meet its cash requirements in the long-term, consistent with Item 303 of Regulation S-K.

Below is an illustrative example of the proposed disclosure that the Company plans to include in the MD&A section titled “Liquidity and Capital Resources” in its Form 10-Q for the quarter ended March 31, 2023 and in its future periodic filings, if applicable, with necessary updates to reflect any subsequent changes of facts, if any. The revisions in response to the Staff’s comment are marked with underlines to facilitate the Staff’s review.

We have financed our operations primarily through payments from university clients and students for our technology and services, the Second Amended Credit Agreement, the 2025 Notes, the 2030 Notes and public and private equity financings. We believe that our existing cash and cash equivalents, together with cash generated from operations and available borrowing capacity under the Second Amended Credit Agreement, will be sufficient to meet our working capital and capital expenditure requirements for the next 12 months. The implementation of the 2022 Strategic Realignment Plan has resulted in improved profitability and we expect this will lead to further profitability improvements going forward. We believe these profitability improvements will be further aided by our long-term revenue contracts. Our ability to support our cash requirements in the long term will depend on many factors, including our ability to realize the anticipated benefits of the 2022 Strategic Realignment Plan and our ability to obtain equity or debt financing on reasonable terms. We regularly evaluate our liquidity position, debt obligations, maturity schedule, and anticipated cash needs, and may consider capital raising, refinancing, and other market opportunities that may be available to us to optimize our balance sheet.

Critical Accounting Policies and Estimates

Goodwill and Other Indefinite-lived Intangible Assets, page 60

Comment

2.

We note goodwill is significant to your balance sheet and that you had two separate impairments for the year ended December 31, 2022. In order to provide investors with more insight into the risk associated with goodwill impairment, please consider disclosing goodwill balances for each reporting unit. To the extent any reporting unit is at risk of impairment, disclose the percentage by which the fair value exceeded the carrying value and describe any potential events and/or changes in circumstances that could reasonably be expected to negatively affect any key assumptions.

Office of Technology

April 21, 2023

Page 3

Response

The Company respectfully acknowledges the Staff’s comment and refers to the disclosure provided on pages 60-61 of the Form 10-K that discusses the impairment charges recorded during the three months ended March 31, 2022 and September 30, 2022, respectively. This disclosure includes a statement that the estimated fair values of the remaining reporting units that were not subject to impairment charges exceeded their respective carrying values by approximately 10% or more and includes a description of the potential events or changes in circumstances that could reasonably be expected to negatively affect any key assumptions.

To the extent it will provide investors with more insight into the risk associated with goodwill impairment, in future periodic filings, the Company will consider disclosing the goodwill balances for each of its reporting units. The following table summarizes the Company’s goodwill balance by reporting unit as of the date indicated (in thousands):

Operating Segment

Reporting Unit

December 31, 2022

Degree Program

Degree Program

$ 192,459

Alternative Credential

Boot Camp

385,718

Alternative Credential

Open Courses

97,157

Alternative Credential

Executive Education

59,286

Total goodwill balance

$ 734,620

In future periodic filings, to the extent any reporting unit is at risk of impairment, the Company will disclose the percentage by which the fair value exceeded the carrying value and describe any potential events and/or changes in circumstances that could reasonably be expected to negatively affect any key assumptions.

Notes to Consolidated Financial Statements

10. Debt, page 95

Comment

3.

We note your disclosure on page 96 states, "The Amended Term Loan Facilities contain a financial covenant that requires the Company to maintain minimum Recurring Revenues." Please tell us and disclose if you were in compliance with your debt covenants for the periods presented.

Response

As of December 31, 2022 and 2021, the Company was in compliance with the debt covenants under the Amended Term Loan Facilities. In future periodic filings, the Company plans to broaden its disclosure related to compliance with financial covenants under the Amended Term Loan Facilities, with necessary updates to reflect changes of facts, if any.

Exhibit 99.1

Reconciliation of Non-GAAP Measures, page 14

Comment

4.

Your calculation of free cash flow differs from the typical calculation of this measure (i.e., cash flows from operations less capital expenditures). In order to avoid potential confusion, please revise the title of your non-GAAP measure to adjusted free cash flow or something similar. Refer to Question 102.07 of the Non-GAAP Compliance and Disclosure Interpretations. Also, revise the title of unlevered free cash flow accordingly.

Response

In future filings, the Company will revise the title of these non-GAAP measures to “adjusted free cash flow” and “adjusted unlevered free cash flow,” respectively.

Office of Technology

April 21, 2023

Page 4

We appreciate the Staff’s time and attention to this matter, and hope that the foregoing has been responsive to the Staff’s comments.. If you have any questions or comments or require further information, please do not hesitate to contact the undersigned at 202-371-7248 or richard.oliver@skadden.com

Very truly yours,
/s/Richard L. Oliver

Show Raw Text
CORRESP
1
filename1.htm

            Skadden, Arps, Slate, Meagher & Flom llp

            DIRECT DIAL

            202-371-7248

            DIRECT FAX

            202-661-0582

            EMAIL ADDRESS

            RICHARD.OLIVER@SKADDEN.COM

            1440 NEW YORK AVENUE, N.W.

            WASHINGTON, D.C.  20005-2111

            ________

            TEL: (202) 371-7000

            FAX: (202) 393-5760

            www.skadden.com

            FIRM/AFFILIATE OFFICES

            -----------

            BOSTON

            CHICAGO

            HOUSTON

            LOS ANGELES

            NEW YORK

            PALO ALTO

            WILMINGTON

            -----------

            BEIJING

            BRUSSELS

            FRANKFURT

            HONG KONG

            LONDON

            MOSCOW

            MUNICH

            PARIS

            SÃO PAULO

            SEOUL

            SHANGHAI

            SINGAPORE

            TOKYO

            TORONTO

    VIA EDGAR

    April 21, 2023

    Mr. Robert Littlepage

    Accounting Branch Chief

    Division of Corporation Finance

    Office of Technology

    Securities and Exchange Commission

    100 F Street, N.E.

    Washington, DC 20549

    Re:          2U, Inc.

    Form 10-K for the Fiscal Year Ended December 31, 2022

    Form 8-K filed February 2, 2023

    File No. 001-36376

    Dear Mr. Littlepage:

    On behalf of our client, 2U, Inc. (the “Company”), we are submitting this letter in response to the comments from the staff (the “Staff”) of the Division of
      Corporation Finance of the Securities and Exchange Commission (the “Commission”) set forth in the letter dated April 10, 2023 (the “Comment Letter”) concerning the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the
      “Form 10-K”) and the Current Report on Form 8-K filed February 2, 2023 (the “Form 8-K”). For convenience, the Staff’s comments are set forth below, followed by the Company’s responses.

    Office of Technology

    April 21, 2023

    Page 2

      Form 10-K for the Fiscal Year Ended December 31, 2022

      Management’s Discussion and Analysis of Financial Condition and Results of Operations

      Liquidity and Capital Resources, page 54

      Comment

          1.

            We note you discuss your ability to meet your working capital and capital expenditure requirements for the next 12 months. Please expand your disclosure to address your ability to generate and
              obtain adequate amounts of cash to meet your cash requirements in the long-term. We refer to guidance in Item 303 of Regulation S-K.

    Response

    In future filings, the Company will expand its disclosure within the Management’s Discussion & Analysis (“MD&A”) section to address its
      ability to generate and obtain adequate amounts of cash to meet its cash requirements in the long-term, consistent with Item 303 of Regulation S-K.

    Below is an illustrative example of the proposed disclosure that the Company plans to include in the MD&A section titled “Liquidity and
      Capital Resources” in its Form 10-Q for the quarter ended March 31, 2023 and in its future periodic filings, if applicable, with necessary updates to reflect any subsequent changes of facts, if any. The revisions in response to the Staff’s comment
      are marked with underlines to facilitate the Staff’s review.

    We have financed our operations primarily through payments from university clients and students for our technology and
      services, the Second Amended Credit Agreement, the 2025 Notes, the 2030 Notes and public and private equity financings. We believe that our existing cash and cash equivalents, together with cash generated from operations and available borrowing
      capacity under the Second Amended Credit Agreement, will be sufficient to meet our working capital and capital expenditure requirements for the next 12 months. The implementation of the 2022 Strategic Realignment
          Plan has resulted in improved profitability and we expect this will lead to further profitability improvements going forward. We believe these profitability improvements will be further aided by our long-term revenue contracts. Our ability to
          support our cash requirements in the long term will depend on many factors, including our ability to realize the anticipated benefits of the 2022 Strategic Realignment Plan and our ability to obtain equity or debt financing on reasonable terms.
      We regularly evaluate our liquidity position, debt obligations, maturity schedule, and anticipated cash needs, and may consider capital raising, refinancing, and other market opportunities that may be available to us to optimize our balance sheet.

    Critical Accounting Policies and Estimates

    Goodwill and Other Indefinite-lived Intangible Assets, page 60

    Comment

          2.

            We note goodwill is significant to your balance sheet and that you had two separate impairments for the year ended December 31, 2022. In order to provide investors with more insight into the
              risk associated with goodwill impairment, please consider disclosing goodwill balances for each reporting unit. To the extent any reporting unit is at risk of impairment, disclose the percentage by which the fair value exceeded the carrying
              value and describe any potential events and/or changes in circumstances that could reasonably be expected to negatively affect any key assumptions.

    Office of Technology

    April 21, 2023

    Page 3

    Response

    The Company respectfully acknowledges the Staff’s comment and refers to the disclosure provided on pages 60-61 of the Form 10-K that discusses
      the impairment charges recorded during the three months ended March 31, 2022 and September 30, 2022, respectively.  This disclosure includes a statement that the estimated fair values of the remaining reporting units that were not subject to
      impairment charges exceeded their respective carrying values by approximately 10% or more and includes a description of the potential events or changes in circumstances that could reasonably be expected to negatively affect any key assumptions.

    To the extent it will provide investors with more insight into the risk associated with goodwill impairment, in future periodic filings, the
      Company will consider disclosing the goodwill balances for each of its reporting units. The following table summarizes the Company’s goodwill balance by reporting unit as of the date indicated (in thousands):

            Operating Segment

            Reporting Unit

            December 31, 2022

            Degree Program

            Degree Program

            $          192,459

            Alternative Credential

            Boot Camp

            385,718

            Alternative Credential

            Open Courses

            97,157

            Alternative Credential

            Executive Education

            59,286

            Total goodwill balance

            $          734,620

    In future periodic filings, to the extent any reporting unit is at risk of impairment, the Company will disclose the percentage by which the
      fair value exceeded the carrying value and describe any potential events and/or changes in circumstances that could reasonably be expected to negatively affect any key assumptions.

    Notes to Consolidated Financial Statements

    10. Debt, page 95

    Comment

          3.

            We note your disclosure on page 96 states, "The Amended Term Loan Facilities contain a financial covenant that requires the Company to maintain minimum Recurring Revenues." Please tell us and
              disclose if you were in compliance with your debt covenants for the periods presented.

    Response

    As of December 31, 2022 and 2021, the Company was in compliance with the debt covenants under the Amended Term Loan Facilities. In future
      periodic filings, the Company plans to broaden its disclosure related to compliance with financial covenants under the Amended Term Loan Facilities, with necessary updates to reflect changes of facts, if any.

    Exhibit 99.1

    Reconciliation of Non-GAAP Measures, page 14

    Comment

          4.

            Your calculation of free cash flow differs from the typical calculation of this measure (i.e., cash flows from operations less capital expenditures). In order to avoid potential confusion,
              please revise the title of your non-GAAP measure to adjusted free cash flow or something similar. Refer to Question 102.07 of the Non-GAAP Compliance and Disclosure Interpretations. Also, revise the title of unlevered free cash flow
              accordingly.

    Response

    In future filings, the Company will revise the title of these non-GAAP measures to “adjusted free cash flow” and “adjusted unlevered free cash
      flow,” respectively.

    Office of Technology

    April 21, 2023

    Page 4

    We appreciate the Staff’s time and attention to this matter, and hope that the foregoing has been responsive to the Staff’s comments.. If you
      have any questions or comments or require further information, please do not hesitate to contact the undersigned at 202-371-7248 or richard.oliver@skadden.com

            Very truly yours,

            /s/Richard L. Oliver

            Richard L. Oliver

            cc:

            Paul S. Lalljie, 2U, Inc.

            Matthew J. Norden, 2U, Inc.

            Hugh W. Mohler, Jr., KPMG LLP

            Inessa Kessman, Securities and Exchange Commission